David Lennard(@dlennard) 's Twitter Profile Photo

I just wanted to say hi and thank you to all those helping me travel through this dimension with some dignity.

I appreciate you ☮️

A RT of my pinned would be fantastic ✨

I  just wanted to say hi and thank you to all those helping me travel through this dimension with some dignity.

I appreciate you ☮️

A RT of my pinned would be fantastic ✨

#thankscancer #multiplemyeloma
account_circle
Poolbeg Pharma(@PoolbegPharma) 's Twitter Profile Photo

Multiple is a type of bone marrow cancer which often affects several areas of the body

The use of cancer immunotherapies to treat cancers including is rapidly growing. is a rate limiting side effect, associated with emerging immunotherapies

account_circle
Blood Cancer Talks(@BloodCancerTalk) 's Twitter Profile Photo

🔥 Tune in to our new episode on maintenance therapy in with Hira Mian & Manni Mohyuddin ! We discuss a wide range of RCTs from CALGB to FORTE, ideal endpoints for maintenance trials, and role of MRD!
tinyurl.com/4mtjyz6m
Here is clip on Dara maint. in CASSIOPEIA!

account_circle
Maria Moscvin(@MMoscvin) 's Twitter Profile Photo

I am happy to announce that I have been selected by @ASH_Hematology to receive the ASH HONORS Award that will provide funding for studying immune reconstitution post CAR-T in ! Grateful for my mentor Surbhi Sidana, MD and StanfordMedRes Stanford Department of Medicine.

I am happy to announce that I have been selected by @ASH_Hematology to receive the ASH HONORS Award that will provide funding for studying immune reconstitution post CAR-T in #multiplemyeloma! Grateful for my mentor @SurbhiSidanaMD and @StanfordMedRes @StanfordDeptMed.
account_circle
GSK US(@GSKUS) 's Twitter Profile Photo

During and every month, we are grateful for all the organizations who support the community by providing resources, support, and awareness for patients and caregivers. Thank you to International Myeloma Foundation, Multiple Myeloma RF, @HealthTreeMM & The Leukemia & Lymphoma Society.

account_circle
J&J Innovative Medicine(@JNJInnovMed) 's Twitter Profile Photo

We are pleased to share that the U.S. FDA has granted approval of our immunotherapy for second-line treatment in patients living with relapsed/refractory .

Discover how we’re delivering critical therapies for those in need: bit.ly/43RXT6N

account_circle
PeerView(@PeerView) 's Twitter Profile Photo

Join Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO, (@bethfaiman), Donna D. Catamero, ANP-BC, OCN, CCRC, & Charise Gleason, MSN, NP-C, AOCNP discuss the latest updates from - to participate, visit: bit.ly/MM24T

account_circle
European Hematology Association(@EHA_Hematology) 's Twitter Profile Photo

Ready to grow your network and your knowledge on pediatric hematology, non-transfusion dependent , , and ? Applications for the , our online clinical preceptorship, are open until June 30.
Learn more: eha.fyi/MC_24/25

account_circle
Oncology Times(@OncologyTimes) 's Twitter Profile Photo

How would you treat this patient with ? Read the case study and choose your next step: focusononcology.com/therapeutic-op…

How would you treat this patient with #MultipleMyeloma? Read the case study and choose your next step: focusononcology.com/therapeutic-op…
account_circle
Oncology Brothers(@OncBrothers) 's Twitter Profile Photo

: w/ Caitlin Costello, MD to discuss Rx options for Newly Diagnosed

Full discussion:
- cancernetwork.com/treatment-algo…
- Oncbrothers.com/newmyeloma-alg…
- Also on the “Oncology Brothers” podcast

CancerNetwork®

account_circle
Multiple Myeloma RF(@theMMRF) 's Twitter Profile Photo

Hear the latest in multiple myeloma care from the experts, Brandon Blue, M.D. (Brandon Blue, MD) of Moffitt Cancer Center on June 8 at CURE®’s Educated Patient® Multiple Myeloma Summit. Learn more and register today! globalmeet.webcasts.com/starthere.jsp?… CURE Today

Hear the latest in multiple myeloma care from the experts, Brandon Blue, M.D. (@DrBlueMD) of @MoffittNews on June 8 at CURE®’s Educated Patient® Multiple Myeloma Summit. Learn more and register today! globalmeet.webcasts.com/starthere.jsp?… #educatedpatient #multiplemyeloma @cure_today
account_circle
JanssenUS(@JanssenUS) 's Twitter Profile Photo

: Today the U.S. FDA approved a new indication for the earlier use of one of our treatments for relapsed/refractory . This marks a significant development in our efforts to expand treatment options for patients in need.

Learn more: prn.to/49vTRCq

account_circle